mammalian
reovirus
among
plethora
virus
present
investig
abil
preferenti
infect
destroy
transformedcanc
cell
led
recent
progress
clinic
use
variou
form
human
cancer
briefli
review
among
other
kelli
et
al
black
morri
contrast
oncolyt
virus
present
consider
clinic
use
reovirus
natur
oncolyt
submit
genet
manipul
clinic
use
fact
possibl
recent
kobayashi
et
al
easili
manipul
reoviru
genom
use
plasmidbas
revers
genet
system
initi
observ
led
util
reoviru
oncolyt
viru
suggest
decreas
activ
interferoninduc
doublestrand
rnadepend
protein
kinas
pkr
occur
upon
rasinduc
cell
transform
respons
preferenti
infect
destruct
cancer
cell
reoviru
strong
et
al
despit
fact
multipl
step
reoviru
replic
cycl
like
involv
preferenti
replic
virusinduc
cancer
cell
death
lemay
et
al
marcato
et
al
work
support
idea
lower
induct
interferon
rastransform
cell
favor
viral
propag
could
major
import
viru
oncolyt
activ
shmulevitz
et
al
support
idea
interferoninduc
antivir
pathway
critic
abil
reoviru
discrimin
parent
rastransform
cell
mutant
viru
obtain
chemic
mutagenesi
select
increas
sensit
interferon
actual
shown
exhibit
complet
blockag
wildtyp
viru
parent
cell
even
extrem
high
multipl
infect
rudd
lemay
multipl
reoviru
gene
suspect
involv
control
interferon
innat
immun
respons
sherri
sherri
et
al
protein
shown
major
determin
factor
control
interferon
signal
induct
alter
subcellular
local
irvin
et
al
zurney
et
al
protein
could
rather
affect
interferon
sensit
due
abil
sequest
dsrna
activ
interferoninduc
protein
kinas
pkr
howev
properti
could
modul
sinc
heterohexam
appear
bind
dsrna
schiff
final
least
cell
type
protein
previous
suspect
play
role
control
either
induct
interferon
signal
viru
sensit
interferon
sherri
et
al
order
clarifi
genet
determin
involv
larg
differ
interferon
sensit
parent
previous
identifi
mutant
viru
rudd
lemay
complet
sequenc
viral
genom
determin
virus
reconstruct
sitedirect
mutagenesi
revers
genet
sinc
number
differ
observ
isol
use
construct
revers
genet
plasmid
parent
laboratori
stock
initi
use
isol
mutant
viru
four
gene
exhibit
differ
parent
mutant
virus
individu
substitut
either
replac
mutant
gene
parent
counterpart
replac
parent
gene
mutant
counterpart
parent
background
clearli
demonstr
singl
amino
acid
substitut
one
two
methyltransferas
domain
major
determin
differ
interferon
sensit
two
virus
order
determin
differ
sequenc
interferonsensit
mutant
rudd
lemay
origin
wildtyp
type
dear
deriv
whole
code
sequenc
genom
analyz
rtpcr
semipurifi
viral
genom
mutant
wildtyp
laboratori
stock
follow
direct
sequenc
pcr
product
describ
section
materi
method
previous
use
laboratori
jabr
et
al
despit
fact
mutant
obtain
follow
treatment
high
dose
chemic
mutagen
nitrosoguanidin
rudd
lemay
gene
found
exhibit
nonsynonym
mutat
compar
wildtyp
result
total
amino
acid
substitut
tabl
uniqu
among
current
avail
sequenc
tabl
data
shown
thu
special
interest
six
addit
silent
nucleotid
substitut
also
found
wildtyp
mutant
viru
genebank
access
number
wildtyp
mutant
complet
sequenc
obtain
also
compar
wildtyp
viru
encod
plasmid
revers
genet
system
kobayashi
et
al
least
one
amino
acid
chang
two
wildtyp
virus
found
seven
protein
complet
ident
protein
first
time
differ
observ
laboratori
stock
socal
reoviru
type
dear
coffey
et
al
nygaard
et
al
yin
et
al
even
lead
design
subtyp
f
field
laboratori
n
nibert
laboratori
c
cashdollar
laboratori
thu
sake
simplic
laboratori
viru
stock
use
present
studi
refer
sandekian
wildtyp
viru
rescu
plasmid
origin
obtain
kobayashi
dermodi
refer
k
kobayashi
addit
amino
acid
substitut
silent
nucleotid
substitut
two
virus
also
found
data
shown
compar
sequenc
analysi
also
perform
sequenc
anoth
complet
genom
refer
w
use
recent
studi
anoth
group
van
den
wollenberg
et
al
sequenc
anoth
laboratori
stock
deposit
ncbi
databas
one
group
refer
h
final
sequenc
viru
current
use
oncolyt
virotherapi
tradenam
reolysin
ad
comparison
chakrabarti
et
al
complet
sequenc
determin
direct
sequenc
viral
genom
retain
analysi
sinc
difficult
assum
sequenc
obtain
earlier
clone
viral
gene
necessarili
repres
would
actual
gener
replicationcompet
viru
combin
togeth
laboratori
subtyp
display
differ
k
compar
complet
sequenc
genom
posit
clearli
variabl
stock
show
presenc
differ
includ
tabl
amino
acid
differ
wildtyp
reoviru
type
dear
laboratori
stock
deriv
mutant
wildtyp
mutant
amino
acid
posit
wildtyp
viru
revers
genet
system
kobayashi
et
al
b
origin
wildtyp
viru
report
studi
c
wildtyp
viru
use
van
den
wollenberg
et
al
wildtyp
unpublish
viru
sequenc
ncbi
databas
e
wildtyp
viru
use
clinic
trial
describ
chakrabarti
et
al
uniqu
substitut
compar
k
thu
seem
stock
subtyp
sequenc
signatur
amino
acid
differ
includ
uniqu
substitut
diverg
k
viru
stock
current
use
differ
laboratori
order
determin
amino
acid
differ
virus
respons
differ
interferon
sensit
two
virus
sitedirect
mutagenesi
use
introduc
chang
revers
genet
plasmid
encod
differ
protein
one
chang
found
protein
correspond
nucleotid
chang
introduc
plasmid
sinc
parent
use
isol
differ
plasmidencod
k
sequenc
complet
set
plasmid
encod
wildtyp
first
construct
subject
sitedirect
mutagenesi
obtain
encod
sequenc
parent
viru
rescu
transfect
correspond
plasmid
combin
virus
similarli
obtain
use
one
gene
background
nine
gene
virus
rescu
propag
describ
materi
method
reciproc
virus
harbor
one
gene
background
nine
gene
also
rescu
propag
infect
replic
abil
differ
virus
examin
cell
infect
multipl
infect
tcid
unit
per
cell
viral
protein
infect
cell
first
examin
immunoblot
fig
first
indic
virus
abl
infect
similar
effici
sinc
appar
differ
amount
viral
protein
produc
product
infecti
viru
next
examin
infect
cell
measur
foldincreas
infecti
viru
fig
either
background
virus
harbor
substitut
singl
gene
viru
appear
significantli
differ
background
viru
background
small
increas
approxim
sixfold
substitut
observ
background
twofold
increas
observ
twofold
decreas
overal
thu
appar
signific
defect
singl
gene
substitut
either
background
establish
differ
rescu
virus
replic
similar
level
absenc
interferon
interferon
sensit
examin
comparison
respect
parent
virus
interferon
sensit
first
examin
measur
titer
reduct
cell
treat
fix
near
satur
concentr
intern
unitsml
describ
materi
method
expect
rescu
harbor
none
gene
exhibit
resist
interferon
titer
almost
unaffect
intern
unitsml
interferon
rescu
show
close
hundredfold
decreas
titer
fig
valu
compar
routin
obtain
two
parent
virus
previou
experi
data
shown
substitut
gene
encod
either
slightli
increas
sensit
interferon
less
tenfold
effect
fig
howev
substitut
gene
encod
significantli
increas
interferon
sensit
render
viru
sensit
viru
reciproc
experi
singl
gene
singli
substitut
background
confirm
suffici
render
viru
resist
protein
slight
essenti
effect
interferon
sensit
fig
appear
unlik
differ
residu
interferon
viral
inocula
could
affect
result
given
freezethaw
treatment
dilut
use
fact
differ
interferon
induct
data
shown
howev
order
rule
possibl
infecti
singl
reassort
virus
recov
human
hela
cell
titrat
murin
cell
presenc
absenc
murin
interferon
condit
interferon
viru
inoculum
human
origin
act
murin
cell
use
interferon
assay
ident
result
obtain
correl
presenc
interferon
sensit
data
shown
interferon
sensit
virus
examin
use
serial
binari
dilut
interferon
plate
stain
quantit
fig
rescu
viru
virus
harbor
singl
gene
background
examin
left
panel
effect
evid
especi
intermedi
concentr
interferon
approxim
iuml
effect
assay
lower
interferon
concentr
compar
fig
protein
also
increas
interferon
sensit
virus
harbor
singl
gene
background
similarli
analyz
fig
right
panel
clearli
affect
interferon
sensit
render
viru
resist
interferon
chang
interferon
sensit
confer
background
reciproc
therefor
examin
present
studi
altogeth
effect
thu
strike
gene
appear
main
like
determin
differ
interferon
sensit
presenc
clearli
suffici
reconstitut
respect
phenotyp
two
virus
repres
multiwel
plate
present
fig
compar
origin
viru
correspond
rescu
viru
gene
singli
substitut
order
rule
possibl
differ
amount
present
infect
cell
infect
immunoblot
perform
rescu
virus
harbor
gene
either
virus
well
virus
harbor
sole
protein
viru
background
reciproc
amount
protein
case
compar
major
outer
capsid
protein
appar
differ
four
virus
fig
simpl
chang
express
stabil
thu
unlik
present
studi
illustr
stateoftheart
plasmidbas
revers
genet
approach
success
use
studi
complet
reconstruct
viru
mutant
previous
identifi
use
classic
genet
techniqu
chemic
mutagenesi
allow
identifi
polymorph
amino
acid
residu
mammalian
orthoreoviru
genom
well
clearli
pinpoint
amino
acid
substitut
drastic
affect
interferon
sensit
viral
strain
previous
mention
protein
previous
identifi
classic
reassort
studi
possibl
molecular
determin
control
interferon
respons
reovirusinfect
cell
howev
first
time
firmli
establish
use
complet
defin
genet
system
interestingli
immunoreceptor
tyrosinebas
activ
motif
itam
could
affect
interferon
signal
pathway
cell
type
observ
although
current
evid
actual
function
steb
et
al
amino
acid
substitut
part
itam
motif
threonin
posit
substitut
methionin
conserv
residu
protein
sequenc
differ
viru
strain
tabl
breun
et
al
locat
one
two
methyltransferas
domain
reinisch
et
al
breun
et
al
bujnicki
rychlewski
still
firmli
establish
first
methyltransferas
domain
respons
subsequ
methyl
cap
structur
howev
sequenc
comparison
suggest
latter
possibl
bujnicki
rychlewski
also
consist
rel
order
two
methyltransferas
domain
cypoviru
anoth
doublestrand
rna
viru
reovirida
famili
methyl
rna
cap
structur
especi
posit
could
import
avoid
recognit
viral
rna
nonself
could
thu
affect
either
induct
interferon
signal
sensit
interferoninduc
antivir
fig
titrat
use
tcid
assay
absenc
presenc
iuml
murin
describ
section
materi
method
averag
foldreduct
viru
titer
independ
experi
sampl
present
logarithm
scale
error
bar
indic
maxim
valu
observ
viru
parent
virus
two
virus
harbor
substitut
gene
virus
background
gene
substitut
statist
alter
interferon
sensit
p
p
respect
use
unpair
student
ttest
protein
recent
review
hyde
diamond
aspect
especi
well
studi
member
flavivirida
famili
also
notic
differ
virus
coronavirus
vesicular
stomat
viru
metapneumoviru
daffi
et
al
zust
et
al
habjan
et
al
kimura
et
al
dong
et
al
kindler
thiel
et
al
menacheri
et
al
alter
methyltransferas
activ
could
thu
potenti
explain
alter
interferon
resist
compar
parent
viru
interestingli
rotaviru
anoth
member
reovirida
famili
cap
enzym
shown
act
antagonist
innat
immun
zhang
et
al
propos
variat
effici
cap
reaction
specif
methyltransferas
activ
examin
determin
could
affect
abil
viru
control
innat
immun
reaction
arnold
et
al
ogden
et
al
interest
perform
similar
studi
protein
reoviru
previou
work
establish
protein
major
determin
extent
interferon
signal
follow
reoviru
infect
zurney
et
al
irvin
et
al
steb
et
al
interferon
induct
compar
recov
supernat
cell
data
shown
supernat
abl
similarli
protect
cell
unrel
murin
encephalomyocard
viru
emcv
use
previou
studi
well
accord
fact
differ
protein
two
virus
thu
probabl
signific
differ
induct
either
interferon
interferoninduc
gene
furthermor
stress
presenc
prolin
posit
indic
virus
rel
although
complet
effici
repress
interferon
signal
irvin
et
al
steb
et
al
suggest
differ
could
rather
resid
differ
sensit
interferoninduc
antivir
mechan
although
remain
firmli
establish
result
present
herein
thu
support
idea
multipl
reoviru
protein
involv
determin
reoviru
sensit
interferon
either
differ
modul
interferon
signal
differ
sensit
interferoninduc
antivir
effector
studi
gene
appear
major
determin
differ
import
multipl
regulatori
mechan
direct
interferon
innat
immun
respons
also
demonstr
rotaviru
arnold
et
al
anoth
member
reovirida
unrel
virus
larg
dna
viru
vaccinia
perdiguero
esteban
well
import
human
rna
virus
hepat
c
qashqari
et
al
influenza
viru
garciasastr
numer
evid
suggest
induct
interferon
antivir
respons
viru
sensit
respons
critic
differenti
abil
viru
replic
kill
differ
cell
type
describ
introduct
also
like
critic
reoviru
oncolyt
abil
possibl
modul
level
interferon
signal
sensit
reoviru
strain
antivir
interferoninduc
gene
combin
variou
mutat
either
could
certainli
contribut
optim
viral
strain
infect
kill
differ
cancer
cell
type
mous
fibroblast
origin
obtain
american
type
cultur
collect
atcc
babi
follow
onehour
adsorpt
period
serial
twofold
dilut
interferon
ad
well
indic
cell
incub
day
fix
stain
methylen
blue
quantifi
describ
section
materi
method
repres
experi
three
independ
experi
present
b
repres
microwel
plate
compar
two
origin
virus
rescu
virus
well
harbor
reciproc
harbor
c
protein
recov
h
postinfect
cell
infect
moi
tcid
unitcel
panel
b
immunoblot
analysi
perform
use
either
monoclon
antibodi
describ
section
materi
method
hamster
kidney
cell
line
bhk
stabli
express
rna
polymeras
describ
buchholz
et
al
gener
gift
laboratori
dr
john
hiscott
ladi
davi
research
institut
canada
cell
line
grown
minim
eagl
medium
mem
fetal
bovin
serum
wildtyp
reoviru
type
dear
origin
obtain
american
type
cultur
collect
reoviru
atcc
laboratori
stock
deriv
pure
plaqu
one
passag
origin
stock
cell
laboratori
viru
stock
thereaft
use
passag
low
multipl
infect
viral
genom
rna
prepar
fragment
sequenc
gener
rtpcr
previous
describ
brochulafontain
lemay
except
vertrel
use
prepar
reoviru
virion
mendez
et
al
sequenc
correspond
gene
wildtyp
laboratori
stock
deposit
access
number
genbank
sequenc
correspond
gene
reoviru
interferonsensit
mutant
access
number
access
number
sequenc
use
comparison
nucleotid
databas
k
protein
databas
h
w
nucleotid
databas
sequenc
reolysin
deduc
differ
notic
gene
refer
sequenc
describ
chakrabarti
et
al
plasmid
separ
harbor
cdna
correspond
gene
reoviru
serotyp
dear
transcript
control
promot
previous
describ
kobayashi
et
al
obtain
laboratori
dr
terenc
dermodi
vanderbilt
univers
nashvil
tennesse
obtain
viru
mutant
specif
gene
correspond
plasmid
directli
submit
sitedirect
mutagenesi
use
recov
infecti
viru
transfect
bhk
cell
express
rna
polymeras
rescu
virus
propag
kinet
viral
replic
viral
titer
assess
previous
describ
brochulafontain
lemay
infect
cell
recov
scrape
small
volum
medium
process
immunoblot
previous
describ
brochulafontain
lemay
immunoblot
perform
use
monoclon
antibodi
direct
either
virgin
et
al
imag
obtain
use
either
autoradiographi
kodak
biomax
light
film
typhoon
imag
ge
healthcar
life
scienc
interferon
sensit
determin
two
differ
approach
reduct
titer
assay
first
use
previous
describ
dani
et
al
briefli
cell
seed
plate
either
left
untreat
pretreat
intern
unit
iu
ml
mous
pbl
interferonsourc
h
use
viru
titrat
tcid
follow
viru
adsorpt
interferon
ad
back
pretreat
plate
reduct
viru
titer
interferontr
cell
compar
untreat
cell
determin
day
postinfect
measur
sensit
virus
differ
concentr
interferon
serial
twofold
dilut
interferon
plate
done
follow
infect
differ
viru
strain
multipl
infect
plate
stain
methylen
blue
previous
describ
imag
obtain
quantit
use
alphaimag
hp
imag
analyz
